Sponsors (8)
The bill increases labeling clarity and regulatory authority to help consumers and traditional producers, but does so at the cost of added compliance expense, potential marketing limits for alternative-protein makers, and possible legal disputes over definitions.
Consumers will see clearer, standardized labeling that identifies cell-cultured or plant-based products, making it easier to know what they're purchasing.
State regulators will have clearer statutory authority via added FD&C Act labeling requirements, improving the government's ability to oversee and enforce labeling of these products.
Traditional meat manufacturers and shoppers will face less marketplace confusion when animal-species names are used only with a clear qualifier, helping producers avoid misbranding disputes and clarifying product identity.
Producers of cell-cultured and alternative-protein products will incur increased labeling and compliance costs to meet the new requirements, raising expenses especially for small producers.
Manufacturers of alternative proteins may face marketing limitations if species names must be qualified, which could reduce product appeal and sales.
Manufacturers and regulators could face legal disputes and regulatory uncertainty over definitions (for example, what qualifies as an 'analogue' or 'cell-cultured'), creating litigation risk and delays in implementation.
Based on analysis of 2 sections of legislative text.
Introduced October 24, 2025 by Roger Williams · Last progress October 24, 2025
Requires that products made from cell-cultured material or products that imitate meat or poultry carry a clear qualifying term or disclaimer immediately before the product name. It defines key terms (cell-cultured product, analogue product, meat, meat food product, poultry) by reference to existing federal definitions and regulations to specify which products are covered.